Belviq (lorcaserin) is a prescription drug used to treat obesity. It works by affecting chemicals in your brain to decrease appetite. Belviq is part of a full weight-loss program which also includes healthy diet and exercise. This medicine can be taken to treat obesity that is related to other conditions such as diabetes, high blood pressure, and high cholesterol. However, Belviq cannot treat these other underlying conditions that are related to obesity. Belviq is an FDA- approved weight-loss medicine. Overweight patients can lose weight and keep the weight off as part of this full weight-loss program. A healthy weight can reduce your risk of other weight-related conditions such as obesity, hypertension, high cholesterol, stroke, and heart attack. Chronic weight management in certain patients. It is used along with a reduced-calorie diet and increased physical activity. Belviq is a serotonin 2C receptor agonist. The exact way Belviq works is not known. It is thought to work in the brain to promote a full feeling and decrease hunger.
Belviq is a medicine used in the treatment of obesity, specifically to help overweight patients lose weight. The active ingredient of the medicine, lorcaserin, works by enhancing the effect of serotonin receptors in the brain - resulting in feelings of fullness and appetite satisfaction. It is used alongside a healthy diet and exercise plan in the treatment of obesity.
Belviq (lorcaserin) is a drug used in weight loss programs. The drug is mostly used to treat obesity related to high blood pressure, diabetes, or high cholesterol. Belviq works by blocking some of the fat and keeping it from being absorbed by your body. Belviq aids the weight loss and at the same decreases the risk of regaining the weight again. It is worth noting that Belviq will not treat other conditions such as diabetes and thus you have to continue taking their medication. However, this weight loss drug is not recommended for pregnant mothers and those below 18 years of age. Belviq is supplied in the form of capsules and should be administered by the oral route with or without food.